ABT vs VRCA · P/E 25, rev $44.33B vs rev $10.9M
Abbott Laboratories (ABT) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the ABT and VRCA stock pages for the full models.
Not investment advice.